HomeInsightsPE

Ortin Global Ltd PE Ratio

Ortin Global Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Ortin Global Ltd

NSE: ORTINGLOBE

PE

-

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Ortin Global Ltd is 0 as of 23 Nov 15:30 PM .
  • The P/E Ratio of Ortin Global Ltd changed from 18.5 on March 2019 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 years.
  • The Latest Trading Price of Ortin Global Ltd is ₹ 19.26 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Ortin Global Ltd

No data available

Company Fundamentals for Ortin Global Ltd

No data available

Image

Ortin Global Ltd

NSE: ORTINGLOBE

Share Price

₹ 19.26

0.39 (2.07%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Ortin Global Ltd

1M

1Y

3Y

5Y

Monitoring Ortin Global Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202419.26
21 Nov 202418.87
19 Nov 202419.79
18 Nov 202418.43
14 Nov 202418.9
13 Nov 202419.05
12 Nov 202419.32
11 Nov 202419.51
08 Nov 202420.53
07 Nov 202421.05

SWOT Analysis Of Ortin Global Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ortin Global Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ortin Global Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Ortin Global Ltd015
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Ortin Global Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Ortin Global Ltd

No data available

* All values are in crore

Historical Revenue of Ortin Global Ltd

No data available

* All values are in crore

Historical EBITDA of Ortin Global Ltd

No data available

* All values are in crore

Historical Net Profit of Ortin Global Ltd

No data available

* All values are in crore

Historical Dividend Payout of Ortin Global Ltd

No data available

* All values are in %

About Ortin Global Ltd

  • Ortin Laboratories Limited was incorporated in October, 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind.
  • The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India.
  • The company is engaged in manufacture of Pharma formulations.
  • They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India.
  • The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations. The company offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers.

Ortin Global Ltd News Hub

News

Ortin Laboratories reports standalone net loss of Rs 0.10 crore in the June 2024 quarter

Net loss of Ortin Laboratories reported to Rs 0.10 crore in the quarter ended June 2024 as...

Read more

2024-08-14 00:00:00

News

Ortin Laboratories announces board meeting date

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 13 Augu...

Read more

2024-08-10 00:00:00

News

Ortin Laboratories schedules AGM

Ortin Laboratories announced that the 37th Annual General Meeting (AGM) of the company wil...

Read more

2024-09-28 00:00:00

News

Ortin Global to convene board meeting

Ortin Global will hold a meeting of the Board of Directors of the Company on 13 November 2...

Read more

2024-11-05 00:00:00

News

Ortin Global reports standalone net loss of Rs 0.47 crore in the September 2024 quarter

Net Loss of Ortin Global reported to Rs 0.47 crore in the quarter ended September 2024 as ...

Read more

2024-11-14 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Ortin Global Ltd

What is the current PE Ratio of Ortin Global Ltd?

The Current PE Ratio of Ortin Global Ltd is 0.0 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Ortin Global Ltd last year?

The PE Ratio of Ortin Global Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Ortin Global Ltd indicate about its stock?

The PE Ratio of Ortin Global Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Ortin Global Ltd.

What is the PE Ratio Growth of Ortin Global Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Ortin Global Ltd grew by -% whereas, the EPS ratio grew by 346.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*